About this trial
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension.
Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Essential hypertension
Disqualifiers
Secondary or resistant hypertension
LVEF<55%
Congenital heart disease
Infiltrative cardiomyopathy
Trial population
Patient with essential hypertension who came to out hospital
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Echocardiohraphy
Diagnostic testTransthoracal echocardiography for diastolic function assessment
Treatment groups
Trial outcomes
Primary outcomes
Diastolic Dysfunction
Diastolic Dysfunction found in transthoracal echocardiography assessment
Sponsors and contacts
Click on the lead sponsor to view all of their trials.